Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 5/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.43 |
| ▸ | AKT1 | P31749 | 2/20 | 0.42 |
| ▸ | FABP7 | O15540 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 2/20 | 0.40 |
| ▸ | TEK | Q02763 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.39 |
| ▸ | CDC7 | O00311 | 3/20 | 0.38 |
| ▸ | UCHL5 | Q9Y5K5 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21151185 | 0.88 | HDAC1 (0.41) | HDAC3HDAC1HDAC6HDAC2HDAC10 | |
| SCHEMBL21150821 | 0.80 | DCUN1D1 (0.41) | HDAC3HDAC1HDAC6HDAC2HDAC10 | |
| SCHEMBL24974628 | 0.78 | GSK3B (0.36) | AKT1FABP7KDRCDC7IKBKB | |
| SCHEMBL24974736 | 0.77 | TACR1 (0.51) | HDAC3HDAC1HDAC6HDAC2HDAC10 | |
| SCHEMBL24974642 | 0.73 | TACR1 (0.39) | AKT1FABP7KDRTEKABCG2 | |
| SCHEMBL24974747 | 0.72 | DYRK3 (0.36) | FABP7DYRK3ROCK2MAPK1CLK2 | |
| SCHEMBL21150824 | 0.72 | DCUN1D1 (0.44) | DCUN1D1TSHR | |
| SCHEMBL21150766 | 0.70 | EGLN1 (0.35) | AKT1FABP7CDC7AURKACHUK | |
| SCHEMBL24974788 | 0.70 | AKT1 (0.37) | AKT1FABP7KDRTEKSIRT2 | |
| SCHEMBL24974591 | 0.69 | TACR1 (0.40) | KDRDYRK3ROCK2MAPK1CLK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572370-B2 | CD16A binding agents and uses thereof | BIOHAVEN THERAPEUTICS LTD. (US) | 2023-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572370-B2 | CD16A binding agents and uses thereof | FCGR1A, FCGR2A, FCGR3B | HDAC3 2964/4885HDAC1 2698/4885HDAC6 3459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.